STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Stereotaxis, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $101.03M
- P/E (TTM)
- –
- Dividend yield
- –
Stereotaxis, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Disposables Service and Accessories [Member] | $22.05M | $21.62M | $22.15M | $21.82M | $21.02M | $19.53M | $18.29M | $17.83M | $17.29M | $17.57M | $18.03M | $18.64M | 73.3% | +4.9% |
| Systems [Member] | $8.02M | $9.58M | $10.22M | $8.25M | $10.78M | $7.98M | $8.63M | $7.31M | $6.46M | $9.53M | $8.74M | $10.87M | 26.7% | -25.6% |
By region
From the segment and revenue-disaggregation notes of Stereotaxis's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.